Vycor Medical
Vycor Medical provides minimal or non-invasive neurosurgical and neurotherapeutic solutions.
Technologies have been validated by numerous independent practitioners and published clinical studies.
IP portfolio of 41 patents and 10 pending.
Public company with management as controlling shareholders (61%)
Two Divisions
Vycor Medical – ViewSite™ Brain Access System (VBAS™): a minimally invasive neurosurgical device designed to improve access to brain lesions while reducing tissue damage and enhancing patient outcomes. The VBAS system is currently used in over 300 hospitals in the US and in numerous countries internationally. VBAS is protected by 41 issued and 10 pending patents and has been validated through 43 peer-reviewed studies. These studies demonstrate that use of VBAS results in: less brain tissue damage; less invasive procedure; improved access and better visibility; and reduced operating and recovery time.
NovaVision – NovaVision Visual Restoration Therapy® (VRT): Only commercialized FDA-cleared therapy for restoration of vision loss as the result of stroke or brain damage. NeuroEyeCoach®: enables dramatic improvements in patients’ ability to detect objects in the visual field by training them to make better eye movements with improvement in over 80% of patients. (FDA registered). Clinically supported by a 296-patient study (the largest to date in the neuro visual space).
High gross margin both divisions: 80%+
Sizeable addressable markets